Employer record · Watertown, MA · FY2023–FY2026

Psivant Therapeutics, Inc.

    Certified LCAs
    3
    FY2024–FY2026
    USCIS approvals
    2
    2 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $166k
    certified LCAs

    Jobs not indexed yet

    Does Psivant Therapeutics, Inc. sponsor H-1B visas?

    Yes — by its record, Psivant Therapeutics, Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 2 USCIS H-1B petition approvals (2 for new employment). Its latest certified LCA in our data was decided May 5, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 4 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Psivant Therapeutics, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2311100%
    FY2632100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Biochemists and Biophysicists 19-10212$159k
    Data Scientists 15-20511$166k

    Most-filed job titles

    1. Data Science Lead1$166k
    2. Modeling & Simulation Scientist1$137k
    3. Principal, Computational Biophysics1$181k

    LCAs per title and median wage offered.

    Where the jobs were

    1. Massachusetts3 LCAs

    We haven't indexed Psivant Therapeutics' jobs yet

    We read jobs straight from employers' own career sites and haven't added Psivant Therapeutics' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • PsiThera (d/b/a)
    • Psivant Therapeutics, Inc. (LCA)
    • PSIVANT THERAPEUTICS, INC. DBA PSITHERA (USCIS)
    • PSIVANT THERAPEUTICS INC (USCIS)

    Psivant Therapeutics, Inc. H-1B: questions people ask

    Does Psivant Therapeutics, Inc. sponsor H-1B visas?

    Yes — by its record, Psivant Therapeutics, Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 2 USCIS H-1B petition approvals (2 for new employment). Its latest certified LCA in our data was decided May 5, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Psivant Therapeutics, Inc. still sponsoring H-1B in 2026?

    Psivant Therapeutics, Inc. had 3 certified LCAs in FY2026 (Oct 2025–Sep 2026), more than the 0 in FY2025. The latest one in our data was decided May 5, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Psivant Therapeutics, Inc. get approved?

    USCIS recorded 2 approvals (2 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Psivant Therapeutics, Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Psivant Therapeutics, Inc.?

    The median wage offered on Psivant Therapeutics, Inc.'s certified LCAs in FY2024–FY2026 was $166k a year. By job title: Data Science Lead $166k (1 LCAs), Modeling & Simulation Scientist $137k (1 LCAs) and Principal, Computational Biophysics $181k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Psivant Therapeutics, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Biochemists and Biophysicists (2) and Data Scientists (1).

    Where are Psivant Therapeutics, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): Massachusetts (3).

    Is Psivant Therapeutics, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Psivant Therapeutics, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Psivant Therapeutics' yet.